This systematic review substantiates the prevalence of mIDH1 in CC and further characterizes clinical, pathologic, and genetic covariates within this sub-population. Co-mutation data may inform future studies of mechanisms of response and resistance to mIDH1-targeted therapies.
No takes yet. Share an insight, caveat, or question.
Boscoe et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: